💨 Abstract

Scientists at the University of Cambridge discovered that aspirin can reduce metastasis in certain cancers by stimulating the immune system. Aspirin does this by decreasing a clotting factor called thromboxane A2 (TXA2), which in turn releases immune cells called T cells from suppression. This discovery may support ongoing clinical trials for the targeted use of aspirin to prevent the spread of susceptible types of cancer.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖